-
China Customs: Russian soybean meal beet meal, etc. are allowed to enter the Chinese market
Time of Update: 2021-01-16
In accordance with the inspection and quarantine requirements in the published annex, imports are permitted: Sugar beet pulp, soybean meal, rapeseed meal, sunflower meal (Sunflower meal) (hereinafter referred to as "meal/cake") refers to beetroot, soybeans, rapeseed, sunflower seeds, etc.
-
China's water-based wood coating is about to enter the summer
Time of Update: 2021-01-15
and upgrading of the furniture industry and the paint industry are inextricable, furniture production links to reduce VOCs emissions, water-based coatings application is an important solution, must be through the industrial chain upstream and downstream
-
Fourtean drug varieties entered the clinical real-world data application pilot in Boao Lecheng Pre-City District
Time of Update: 2021-01-14
to the Chinese market, for domestic patients to provide more choices for drug use, but also to enable more Chinese patients to benefit from innovative drugs and medical devices. ," Li said. Gu Gang, director of the Lecheng Advance District
-
Clin cancer res: The results of the first clinical trial of the anti-tumor necrotic necrotogenic
Time of Update: 2021-01-14
A: Tumor size changes in extended cohort patients; B:ICI initial treatment patients' response and duration in dose incremental cohorts (n-45), the combined treatment group had a period of objective remission (ORR 2.2%).
-
Eight departments issued a text, did not enter the clinical path of drugs or large-scale elimination!
Time of Update: 2021-01-13
patients from level 3 hospitals and 70% of discharged patients from level 2 hospitals should be managed according to clinical pathways. the effect of clinical path control significantly standardizes medical behavior and promotes rational medical
-
One person suspected of tampering with the test results, after entering the country confirmed! The Chinese Embassy in Russia informed
Time of Update: 2021-01-13
Recently, the Chinese Embassy in Russia in the anti-russian import case nucleic acid and serum antibody test report found that a Chinese citizen suspected of tampering with the test results, the relevant situation is as follows: in mid-December
-
Merca East entered TCE to develop a new cancer immunotherapy
Time of Update: 2021-01-12
Recently, Mercator struck a potentially $1 billion strategic partnership with San Diego-based Janux Therapeutics to develop next-generation T-cell joint (TCE) immunotherapy for cancer treatments.
-
One Week Finance China Red Bull 2020 sales 22.8 billion Ipson teamed up with Commes to enter big health
Time of Update: 2021-01-12
will have independent intellectual property rights suitable for Chinese intestinal health strains and applications, the current company's probiotic product group to carry out secondary creation, comprehensive upgrade of existing product quality, improve
-
Shenyang, Liaoning Province immediately launched an emergency response to fully enter a war-time state
Time of Update: 2021-01-12
city of Shenyang immediately launched an emergency response, fully into a war-time state, all-round investigation of risk personnel, resolutely prevent the spread of the epidemic.
-
Beijing Shunyi the source of this outbreak to find out! Enter asymptomatic infections from outside Indonesia
Time of Update: 2021-01-12
in recent months is not a new variant strain in the United Kingdom or South Africa. , the case report as of December 29 at 24:00, the local cluster outbreak in Shunyi District involved a total of 16 cases of new coronary pneumonia virus infection
-
Con C.K.-Ipson teamed up with Commes to enter Big Health's Compit to end a small IPO of select tiers
Time of Update: 2021-01-12
series of health food products owned by the Conlon Group of the United States. was founded in 1991, through the United States GMP certification, research and development, production, sales as one of the high-quality, all-natural nutrition
-
Thousands of calls began to come out, Karelli Zhu single resistance successfully entered the new version of the national health insurance directory
Time of Update: 2021-01-11
of lung cancer, led by Professor Zhou Caizhu of Shanghai Lung Hospital affiliated with Tongji University, the results of the world's first phase III study (CameL study) of non-squamous non-small cell lung cancer (NSCLC) first-line immunogenic combined
-
Enter the set! Koren's another heavy injection was the first!
Time of Update: 2021-01-11
new drug research and development monitoring database (CPM) shows that in China's Moxiza star mainly oral regular release agents, injections and eye drops three dosage forms, and are health insurance varieties.
-
The first systemic in vivo CRISPR therapy has entered clinical trials
Time of Update: 2021-01-10
in non-human primate models, the therapy reduced the expression level of TTR protein by more than 95 percent after a treatment and lasted at least a year.
-
The news is coming out! These drugs are expected to enter the base drug catalogue
Time of Update: 2021-01-08
Pharmaceutical network November 19 - health insurance-based drugs or become agents in the system of chicken ribs, good development but not money-making base drugs the latest news came out yesterday, the national basic drug management methods
-
The news is coming out! These drugs are expected to enter the base drug catalogue
Time of Update: 2021-01-08
Yesterday, the national management measures for the management of base drugs to solicit views and discuss the minutes of the meeting circulated in the industry. Next year, the focus of the adjustment of the focus of the drug also came out: 1
-
Li Lanxuan: "Internet plus health care" will enter the 3.0 era
Time of Update: 2021-01-08
, hosted by the European and American Students Association (China Students Association), Yinchuan City People's Government 2020 China (Yinchuan) Health Industry High Quality Development Forum held in Yinchuan, Ningxia, Chinese Academy of Engineering
-
China's mining industry has entered a period of deep adjustment
Time of Update: 2021-01-07
2016, China's mining investment in fixed assets was 305.4 billion yuan, down 16.4% YoY, and the decline continued to expand by 1.1 percentage points from the January-April average. In terms of private fixed asset investment, investment in the mining
-
And platinum medicine through the Hong Kong Stock Exchange hearing 4 innovative candidate drugs have entered the clinical stage
Time of Update: 2021-01-07
FcRn inhibitor Bartoli monoant (HBM9161): a product introduced by And Platinum Pharmaceuticals and enjoying the development and commercialization interests of Greater China.
-
First sound pharmaceutical stroke new drugs must first enter the ® health insurance directory
Time of Update: 2021-01-05
In recent years, with the increasing attention of China's pharmaceutical industry to independent innovation, coupled with the adjustment of medical insurance policy, more and more patients can more timely enjoy the fruits of innovative drugs
